Managing disruptive behaviors with neuroleptics: treatment options for older adults in nursing homes.

作者: Philippe Voyer , René Verreault , Pamphile Nkogho Mengue , Danielle Laurin , Louis Rochette

DOI: 10.3928/0098-9134-20051101-11

关键词:

摘要: Disruptive behaviors are frequent among elderly individuals in long-term care centers. Neuroleptics remain the most common pharmacological treatment for controlling these challenging behavioral manifestations. However, their effectiveness is a subject of controversy and it unclear what specific more likely to be managed with neuroleptic medications. The objective this study was identify types disruptive which neuroleptics given facilities determine if frequency increases risk being prescribed neuroleptics. A cross-sectional conducted 2,332 participants ages 65 or older living 28 facilities. Among them, 27.8% had taken at least one drug prior week. administration not linked presence any behavior. significant finding that greater behavior exhibited by an individual, them administered medication. multi-dimensional approach assessment recommended facilitate identification underlying causes those behaviors. Accordingly, suggested non-pharmacological plans adapted each situation then implemented potentially reduce use

参考文章(45)
Philip Seeman, Atypical Antipsychotics: Mechanism of Action: The Canadian Journal of Psychiatry. ,vol. 47, pp. 27- 38 ,(2002) , 10.1177/070674370204700106
J. H. Ellgring, Depression, psychosis, and dementia: impact on the family. Neurology. ,vol. 52, ,(1999)
Lehninger Fw, Stewart Jt, Ravindran Vl, Management strategies for problem behaviors in the patient with dementia. Geriatrics. ,vol. 53, pp. 55- ,(1998)
Beck Ck, Shue Vm, Interventions for treating disruptive behavior in demented elderly people. Nursing Clinics of North America. ,vol. 29, pp. 143- 155 ,(1994)
M. Enserink, Are Placebo-Controlled Drug Trials Ethical? Science. ,vol. 288, pp. 416- 416 ,(2000) , 10.1126/SCIENCE.288.5465.416A
Richard A. Lehne, Pharmacology for Nursing Care ,(1990)
E. Crosse, T. Ostbye, Net economic costs of dementia in Canada. Canadian Medical Association Journal. ,vol. 151, pp. 1457- 1464 ,(1994)
Edmund Lonergan, Jay Luxenberg, John M Colford, Jacqueline Birks, Haloperidol for agitation in dementia Cochrane Database of Systematic Reviews. ,(2002) , 10.1002/14651858.CD002852
Andrew E. Falsetti, Risperidone for control of agitation in dementia patients. American Journal of Health-system Pharmacy. ,vol. 57, pp. 862- 870 ,(2000) , 10.1093/AJHP/57.9.862